The peptide is stable in gastric acid, which makes oral administration viable for gut-targeted applications, a property that distinguishes it from many other therapeutic peptides that degrade before reaching target tissue
Tissue Health May assist in supporting normal tissue integrity, including muscles, tendons, and ligaments, as part of a recovery-focused program
If you check these labs and see that your MCV is greater than 92 and that your homocysteine is greater than 10.0 there is a HIGH chance that your B12 levels are NOT optimized
Peptide Vials (BPC-157 + TB-500 20 mg Blend): 4 weeks (28 doses at ~0.671.0 mg/day): 2 vials 6 weeks (42 doses): 3 vials 8 weeks (56 doses): 34 vials Insulin Syringes (U-100): Per week: 7 syringes (1/day) 4 weeks: 28 syringes 6 weeks: 42 syringes 8 weeks: 56 syringes Bacteriostatic Water (10 mL bottles): Use 3.0 mL per vial for reconstitution
Passive diffusion accounts for about 1% of total absorption, and this route of absorption is unaffected in patients with pernicious anemia ( There were studies in the 1950s and the1960s that showed that oral vitamin B12 could be absorbed by patients with pernicious anemia and could lead to resolution of the anemia ( The objective of our review is to inform clinicians on the effectiveness of oral vitamin B12 as adequate replacement in patients with pernicious anemia, as well as make recommendations on the dosing and frequency of clinical and laboratory monitoring